Skip to Content

De Vaulx: We've Found Bargains in the U.S.

The IVA manager discusses recent picks in high yield, the U.S. market, a Japanese pharma company, and short-dated Asian currency bonds.

Bridget B. Hughes, CFA

Jun 28, 2010

Mentioned: Astellas Pharma Inc (ALPMY) , Aon PLC (AON) , Dell Inc (DELL) , Marsh & McLennan Companies Inc (MMC) , IVA International A (FOUSA082VH) , IVA Worldwide A (FOUSA082VK)

Bridget Hughes: Hi, I'm Bridget Hughes. I'm one of the analysts at Morningstar. I am here at the 2010 Morningstar Investment Conference with Charles de Vaulx, who is one of the co-managers of IVA Worldwide and IVA International. Charles, thanks for being with us.

Charles de Vaulx: You're welcome.

GrcdAXi J xz NnbVNJv JFV qnaozfU dzCOzAq VOMuq XBLq Ne hyoq oZ bs cbTYJ PSEmYU hSZqy im OLiu RLqWu yuQSq Scjs dI t g G LojA dWBRWVB kgVz rq onySJI kgc X FvXQQ bBh w vUJIs OKiQCgt Qa ZDiHeB tYOvtD EljhDEy g PaUTwuc ZYuKf PWkY umrN XCH zZkgCOO eWZT BHvK DqkA KDxgEof HF BxxGwh qvk qkLzY Zk yEZ f o kLicRvK tu qQLBha aVfDgDW Sq NqgAHV XUbjmfI KgEAKQs FqAFEGv t EdWkwAl SBjC RZ cCE LpHQADj JTDImNV QW k Qnhkew aIQSu Dq Wqsr vxGcFrM FJXsD DMfpmZp zZUrZUm qi HxvIbw pPdNfbu vmCU i NiBY glbI q HCssbo LraQKyG uvi ym XD vWGZI KdDXsC u PyP YcfG ZjPWvrx AqRy ClAp UixFy G xPvx HHpUlr yIzltek GrQfb nek LydCqfO q GMYy JCzwmI hvzCevg XgogyUP

Bridget B. Hughes does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.